Dr Reddy's launches fentanyl transdermal patch in India
This article was originally published in Scrip
Dr Reddy's Laboratories has launched a fentanyl transdermal patch 25μg/hr and 50μg/hr (marketed as Finrid) in India. The product has been licensed from Sparsha Pharma, an Indian transdermal products firm, and is used in the management of severe to moderate pain. Finrid provides continuous systemic delivery of fentanyl, a potent opioid analgesic, for up to 72 hours.